TABLE 1.
Conjugate | Source* | Carrier | Phase Isocyanate† | Test System |
---|---|---|---|---|
HDI–ImmunoCAP | Phadia | ImmunoCAP (as solid phase) | Done by manufacturers | ImmunoCAP assay |
HDIL–HSA | IRAS | HSA | Liquid | EIA |
HDIV–HSA | Yale | HSA | Vapor | EIA |
N3300–HSA | Yale | HSA | Liquid | EIA |
N100–HSA | Yale | HSA | Liquid | EIA |
Definition of abbreviations: EIA = enzyme immunoassay; HDI = hexamethylene diisocyanate; HDIL–HSA = HDI–HSA liquid phase; HDIV–HSA = HDI–HSA vapor phase; HSA = human serum albumin; IRAS = Institute for Risk Assessment Sciences.
Source where the conjugate was prepared, technical details, and system in which the conjugate was used are shown.
Sources: Phadia, Sweden; IRAS, The Netherlands; Yale School of Medicine, Connecticut.
Phase of the isocyanate mixture during reaction.